{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-PRIME/4554",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Fuji Pharma Co.,Ltd. (Prime Market: 4554) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nFuji Pharma Co.,Ltd. is listed on the Prime Market under ticker 4554, ISIN JP3816200004 and LEI 529900L1XVCEHVKHAM60. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 6 filings in the twelve months to 2026-11-06, on 3 filing days. Of the filings, 1 is ad hoc, 3 are regulatory filings and 2 are results. The median gap between filing days is 73.0 days. The latest filing is dated 2026-05-13, a regulatory filing, 177 days before the record date. The Prime Market median is 29.0 days of cadence gap, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical median is 49.5 days of cadence gap, 8.0 filings and 85.0 days of latency across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors, the signal is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 3 research houses: Tokai Tokyo Intelligence Laboratory Co., Ltd., Toyo Securities Co., Ltd. and Mizuho Securities Co., Ltd.\n\n## Open research\n\nThe record holds 1 openly published research note: FISCO Ltd., dated 2026-01-20.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.\n\n## Sources\n\n11 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4554 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XAU2 (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.fujipharma.jp/english/ir/stock/ (coverage)\n- https://www.fujipharma.jp/english/__upload/EN_sr_report_202601.pdf (open research)\n- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4554 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XAU2",
    "state": "sourced",
    "value": "有限責任 あずさ監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-PRIME/4554",
  "coverage": {
   "count": 3,
   "houses": [
    {
     "analyst": "Masao Yoshida",
     "house": "Tokai Tokyo Intelligence Laboratory Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.fujipharma.jp/english/ir/stock/",
     "state": "sourced"
    },
    {
     "analyst": "Eiichiro Haizuka",
     "house": "Toyo Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.fujipharma.jp/english/ir/stock/",
     "state": "sourced"
    },
    {
     "analyst": "Yuriko Ishida",
     "house": "Mizuho Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.fujipharma.jp/english/ir/stock/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.fujipharma.jp/english/ir/stock/",
     "result": "read: 3 of 6 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1557,
     "median_cadence_gap_days": 29,
     "median_filings": 10,
     "median_latency_days": 70,
     "name": "Prime Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 73,
   "filing_days": 3,
   "filings": 6,
   "latency_days": 177,
   "latest": [
    {
     "category": "135",
     "date": "2026-05-13",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Y2Z8",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-05-13",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Y2Z6",
     "title": "半期報告書－第62期(2025/10/01－2026/09/30)",
     "type": "results"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2025-12-22",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XC4F",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "135",
     "date": "2025-12-18",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XB9U",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "235",
     "date": "2025-12-18",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XB9R",
     "title": "内部統制報告書－第61期(2024/10/01－2025/09/30)",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-05-13",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4554",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Prime Market"
   },
   "isin": {
    "read_by": "GLEIF ISIN list for the LEI (lei-records/<lei>/isins) (the one equity-pattern ISIN JP3…00x)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest (isin-lei-latest.zip, ISINs mapped to the LEI)",
    "state": "sourced",
    "value": "JP3816200004"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN JP3816200004)",
    "state": "sourced",
    "value": "529900L1XVCEHVKHAM60"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Fuji Pharma Co.,Ltd."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4554"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:d932dc2763d398c3a00de948ca35d7dd9042511cf576a76fa0ebb8e2d4687a2b",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2026-01-20",
     "kind": "issuer-sponsored",
     "publisher": "FISCO Ltd.",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.fujipharma.jp/english/__upload/EN_sr_report_202601.pdf",
     "state": "sourced",
     "title": "FY2025_Company Research and Analysis Report - Fuji Pharma Co., Ltd."
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope and the subject's record carries no instrument class to place within it",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4554",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:d932dc2763d398c3a00de948ca35d7dd9042511cf576a76fa0ebb8e2d4687a2b",
 "path": "/jp/TSE-PRIME/4554",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Fuji Pharma Co.,Ltd. is listed on the Prime Market under ticker 4554, ISIN JP3816200004 and LEI 529900L1XVCEHVKHAM60. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 6 filings in the twelve months to 2026-11-06, on 3 filing days. Of the filings, 1 is ad hoc, 3 are regulatory filings and 2 are results. The median gap between filing days is 73.0 days. The latest filing is dated 2026-05-13, a regulatory filing, 177 days before the record date. The Prime Market median is 29.0 days of cadence gap, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical median is 49.5 days of cadence gap, 8.0 filings and 85.0 days of latency across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors, the signal is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 3 research houses: Tokai Tokyo Intelligence Laboratory Co., Ltd., Toyo Securities Co., Ltd. and Mizuho Securities Co., Ltd.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 1 openly published research note: FISCO Ltd., dated 2026-01-20.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "11 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4554"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XAU2"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.fujipharma.jp/english/ir/stock/"
  },
  {
   "for": "open research",
   "source": "https://www.fujipharma.jp/english/__upload/EN_sr_report_202601.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4554"
  }
 ],
 "title": "Fuji Pharma Co.,Ltd. (4554) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}